Futura Medical plc (LON:FUM – Get Free Report)’s stock price traded up 11.8% on Tuesday . The company traded as high as GBX 14.98 ($0.19) and last traded at GBX 14.98 ($0.19). 343,060 shares traded hands during trading, a decline of 60% from the average session volume of 864,320 shares. The stock had previously closed at GBX 13.40 ($0.17).
Futura Medical Stock Up 11.8 %
The company has a market cap of £45.30 million, a PE ratio of -1,498.00 and a beta of 1.25. The stock’s 50 day simple moving average is GBX 29.62 and its two-hundred day simple moving average is GBX 33.12.
About Futura Medical
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.
See Also
- Five stocks we like better than Futura Medical
- What is the Nikkei 225 index?
- Onsemi Stock: Signs Point to a Powerful Rebound
- The Most Important Warren Buffett Stock for Investors: His Own
- Monday.com Stock Could Soar to New Highs—Here’s How
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Merck: 4 No-Brainer Reasons to Buy This Dip
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.
